|
Market Closed -
Nasdaq
04:00:00 17/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 59.24 USD | -2.87% |
|
-8.44% | -22.01% |
| 10-15 | UBS Adjusts Price Target on PTC Therapeutics to $90 From $80, Maintains Buy Rating | MT |
| 10-08 | RBC Cuts Price Target on PTC Therapeutics to $75 From $85, Keeps Sector Perform Rating | MT |
| Market Cap | 4.94B 4.39B 4.07B 3.71B 6.99B 469B 7.11B 48.96B 19.2B 245B 18.56B 18.16B 781B | P/E 2026 * |
42.2x | P/E 2027 * | 25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.07B 2.73B 2.53B 2.3B 4.35B 292B 4.42B 30.43B 11.93B 152B 11.53B 11.29B 485B | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.03x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTCT | Delayed | |
CBOE
| PTCT | Real-time | |
|
Deutsche Boerse AG
| BH3 | Delayed | |
|
Tradegate
| BH3 | Real-time | |
|
Börse Stuttgart
| BH3 | Delayed | |
|
Boerse Muenchen
| BH3 | Real-time | |
|
Xetra
| BH3 | Delayed |
Last Transcript: PTC Therapeutics, Inc.
| 1 day | -2.87% | ||
| 1 week | -8.44% | ||
| Current month | -8.55% | ||
| 1 month | -12.88% | ||
| 3 months | -24.62% | ||
| 6 months | -18.21% | ||
| Current year | -22.01% |
| 1 week | 58.8 |  | 65.02 |
| 1 month | 58.8 | | 66.58 |
| Current year | 58.8 | | 90.87 |
| 1 year | 58.8 | | 90.87 |
| 3 years | 17.53 | | 90.87 |
| 5 years | 17.53 | | 90.87 |
| 10 years | 4.03 | | 90.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 22/03/2023 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 13/07/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 01/11/2004 | |
Allan Jacobson
CHM | Chairman | 80 | 31/03/1998 |
David Southwell
BRD | Director/Board Member | 65 | 01/12/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Exercice | General Counsel | 576 | 0.0007% | ||
| 7/10/26 | Other | Chairman | 0 | 0% | ||
| 7/10/26 | Section Six Partners
| Sell | Company | -2,500 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.87% | -8.44% | -10.17% | +187.43% | 4.94B | |
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | |
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | |
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | |
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | |
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | |
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | |
| Average | -0.45% | +2.41% | +29.95% | +73.87% | 394.58B | |
| Weighted average by Cap. | +0.13% | +3.82% | +39.27% | +71.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.12B 1.04B 942M 1.78B 119B 1.81B 12.45B 4.88B 62.25B 4.72B 4.62B 198B | 1.38B 1.22B 1.13B 1.03B 1.95B 131B 1.98B 13.64B 5.35B 68.22B 5.17B 5.06B 217B |
| Net income | 130M 115M 107M 97.14M 183M 12.3B 186M 1.28B 503M 6.42B 486M 476M 20.46B | 200M 178M 165M 150M 283M 18.99B 288M 1.98B 777M 9.91B 751M 735M 31.6B |
| Net Debt | -1.87B -1.66B -1.54B -1.4B -2.65B -178B -2.69B -18.53B -7.27B -92.67B -7.02B -6.87B -295B | -2.15B -1.91B -1.77B -1.61B -3.03B -204B -3.08B -21.25B -8.33B -106B -8.05B -7.88B -339B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$59.24 | -2.87% | 788,980 |
| 15/10/26 | US$60.99 | +2.21% | 1,051,889 |
| 14/10/26 | US$59.67 | -0.42% | 1,519,817 |
| 13/10/26 | US$59.92 | -4.77% | 1,051,413 |
| 12/10/26 | US$62.92 | -2.75% | 745,205 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
